Dr. Ponvilawan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2301 Holmes St
Kansas City, MO 64108Phone+1 816-404-4175Fax+1 816-404-0003
Education & Training
- Siriraj Medical School/Mahidol UniversityClass of 2018
Certifications & Licensure
- MO State Medical License 2022 - 2025
Publications & Presentations
PubMed
- Long-Term Survival by Number of Immune Checkpoint Inhibitors in PD-L1-Negative Metastatic NSCLC: A Systematic Review and Meta-Analysis.Ben Ponvilawan, Dhruv Bansal, Nagla Abdel Karim, Rahul Ramakrishnan, Janakiraman Subramanian
JAMA Network Open. 2025-02-03 - A review on disease modifying pharmacologic therapies for sickle cell disease.Himil Mahadevia, Ben Ponvilawan, Ujjwal Madan, Parth Sharma, Hana Qasim
Annals of Hematology. 2025-01-20 - Clinical outcomes and adverse events of Hedgehog pathway inhibitors for advanced basal cell carcinoma patients: A systematic review and meta-analysis.Suvijak Untaaveesup, Wichapol Dendumrongsup, Pornteera Srichana, Chanamon Pongphaew, Gynna Techataweewan
Heliyon. 2025-01-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: